Your browser doesn't support javascript.
loading
Integrating Tertiary Gleason 5 Patterns into Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens.
Sauter, Guido; Clauditz, Till; Steurer, Stefan; Wittmer, Corinna; Büscheck, Franziska; Krech, Till; Lutz, Florian; Lennartz, Maximilian; Harms, Luisa; Lawrenz, Lisa; Möller-Koop, Christina; Simon, Ronald; Jacobsen, Frank; Wilczak, Waldemar; Minner, Sarah; Tsourlakis, Maria Christina; Chirico, Viktoria; Weidemann, Sören; Haese, Alexander; Steuber, Thomas; Salomon, Georg; Matiu, Michael; Vettorazzi, Eik; Michl, Uwe; Budäus, Lars; Tilki, Derya; Thederan, Imke; Pehrke, Dirk; Beyer, Burkhard; Fraune, Christoph; Göbel, Cosima; Heinrich, Marie; Juhnke, Manuela; Möller, Katharina; Bawahab, Ahmed Abdulwahab Abdullah; Uhlig, Ria; Huland, Hartwig; Heinzer, Hans; Graefen, Markus; Schlomm, Thorsten.
Afiliação
  • Sauter G; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: g.sauter@uke.de.
  • Clauditz T; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Steurer S; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Wittmer C; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Büscheck F; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Krech T; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Lutz F; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Lennartz M; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Harms L; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Lawrenz L; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Möller-Koop C; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Simon R; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Jacobsen F; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Wilczak W; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Minner S; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Tsourlakis MC; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Chirico V; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Weidemann S; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Haese A; Martini-Klinik, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Steuber T; Martini-Klinik, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Salomon G; Martini-Klinik, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Matiu M; Department of Ecoclimatology, Technical University Munich, Munich, Germany.
  • Vettorazzi E; Department of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Michl U; Martini-Klinik, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Budäus L; Martini-Klinik, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Tilki D; Martini-Klinik, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Thederan I; Martini-Klinik, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Pehrke D; Martini-Klinik, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Beyer B; Martini-Klinik, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Fraune C; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Göbel C; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Heinrich M; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Juhnke M; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Möller K; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Bawahab AAA; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Uhlig R; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Huland H; Martini-Klinik, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Heinzer H; Martini-Klinik, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Graefen M; Martini-Klinik, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Schlomm T; Martini-Klinik, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, Section for Translational Prostate Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Eur Urol ; 73(5): 674-683, 2018 05.
Article em En | MEDLINE | ID: mdl-28117112
BACKGROUND: Presence of small (tertiary) Gleason 5 pattern is linked to a higher risk of biochemical recurrence in prostate cancer. It is unclear, however, how to integrate small Gleason 5 elements into clinically relevant Gleason grade groups. OBJECTIVE: To analyze the prognostic impact of Gleason 5 patterns in prostate cancer and to develop a method for integrating tertiary Gleason 5 patterns into a quantitative Gleason grading system. DESIGN, SETTING, AND PARTICIPANTS: Prostatectomy specimens from 13 261 consecutive patients and of 3295 matched preoperative biopsies were available. Percentages of Gleason 3, 4, and 5 had been recorded for each cancer. Outcome measurements and statistical analysis: RESULTS AND LIMITATIONS: Our data demonstrate that minimal Gleason 5 areas have strong prognostic impact in Gleason 7 carcinomas, while further expansion of the Gleason 5 pattern population has less impact. We thus defined an integrated quantitative Gleason score (IQ-Gleason) by adding a lump score of 10 to the percentage of unfavorable Gleason pattern (Gleason 4/5) if any Gleason 5 was present and by adding another 7.5 points in case of a Gleason 5 fraction >20%. There was a continuous increase of the risk of prostate-specific antigen recurrence with increasing IQ-Gleason. This was also true for subgroups with identical Cancer of the Prostate Risk Assessment Postsurgical scores (p<0.0001) or Gleason grade groups (p<0.0001). CONCLUSIONS: The IQ-Gleason represents a simple and efficient approach for combining both quantitative Gleason grading and tertiary Gleason grades in one highly prognostic numerical variable. PATIENT SUMMARY: Prostatectomy specimens (13 261) were analyzed to estimate the relevance of small Gleason 5 elements in prostate cancers. Even the smallest Gleason 5 areas markedly increased the risk of prostate-specific antigen recurrence after surgery. Larger fractions of Gleason 5 patterns had less further impact on prognosis. Based on this, a numerical Gleason score (integrated quantitative Gleason score) was defined by the percentages of Gleason 4 and 5 patterns, enabling a refined estimate of patient prognosis.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Gradação de Tumores / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Eur Urol Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Gradação de Tumores / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Eur Urol Ano de publicação: 2018 Tipo de documento: Article